Immuneering Corporation IMRX announced that it has submitted an investigational new drug (IND) application to the FDA to begin a clinical study on its lead product candidate IMM-1-104 for the ...

(RTTNews) - Immuron (IMRN) said it has filed a pre-IND application with the FDA for IMM-529. The company is developing IMM-529 as an adjunctive therapy in combination with standard of care antibiotics ...